EU considers COVID-19 vaccine patent waiver but Germany, drugmakers push back
Published
Germany, the European Union's biggest economic power and home to a large pharmaceutical sector, has rejected the idea of waiving intellectual property rights for COVID-19 vaccines after the US threw its support behind a waiver.
Full Article